Italia markets closed
FTSE MIB
25.892,18 -590,03 (-2,23%) Dow Jones
32.249,02 +143,77 (+0,45%) Nasdaq
11.820,24 +32,84 (+0,28%) Nikkei 225
27.385,25 -34,36 (-0,13%) Petrolio
69,32 -0,64 (-0,91%) Bitcoin EUR
25.888,38 -79,54 (-0,31%)
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
Al 03:32PM EDT. Mercato aperto.
Caricamento grafico interattivo in corso...
- GlobeNewswire
Knight Therapeutics Announces Regulatory Submission for Tafasitamab in Brazil
MONTREAL, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a marketing authorization application for tafasitamab in combination with lenalidomide to ANVISA, the Brazilian health regulatory agency, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for auto
© 2023 Yahoo. Tutti i diritti riservati.
